BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.692
-0.498 (-41.82%)
At close: Dec 20, 2024, 4:00 PM
0.730
+0.038 (5.45%)
After-hours: Dec 20, 2024, 7:45 PM EST
BioAtla Employees
BioAtla had 65 employees as of December 31, 2023. The number of employees decreased by 1 or -1.52% compared to the previous year.
Employees
65
Change (1Y)
-1
Growth (1Y)
-1.52%
Revenue / Employee
$169,231
Profits / Employee
-$1,258,723
Market Cap
33.47M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65 | -1 | -1.52% |
Dec 31, 2022 | 66 | 10 | 17.86% |
Dec 31, 2021 | 56 | 20 | 55.56% |
Dec 31, 2020 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
Atara Biotherapeutics | 225 |
WORK Medical Technology Group LTD | 216 |
DBV Technologies | 105 |
Scilex Holding Company | 105 |
Aadi Bioscience | 89 |
Immuneering | 68 |
Modular Medical | 40 |
BCAB News
- 1 day ago - BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points - GlobeNewsWire
- 5 days ago - BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - GlobeNewsWire
- 11 days ago - BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - GlobeNewsWire
- 6 weeks ago - BioAtla, Inc. (BCAB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy - Seeking Alpha
- 2 months ago - BioAtla: Numerous Catalysts Coming In Q4 - Seeking Alpha
- 2 months ago - BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 2 months ago - BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress - GlobeNewsWire